Co-Diagnostics submits FDA 510(k) for Co-Dx PCR Flu A/B & RSV point-of-care test - CODX News | RalliesCo-Diagnostics submits FDA 510(k) for Co-Dx PCR Flu A/B & RSV point-of-care test
C
CODX• FDA filing for point-of-care PCR test
- Co-Diagnostics submitted a 510(k) premarket notification to the FDA for its Co-Dx PCR Flu A/B & RSV upper-respiratory multiplex test.
- Filing covers use on the Co-Dx PCR Pro instrument, part of its point-of-care PCR platform targeted for a potential US launch.
•
